AI-First Business Models Seek to Reshape Drug Discovery Post date March 21, 2025 ← AION Labs Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations → Study validates DenovAI’s platform for programmable de novo-designed protein therapeutics